piperacillin has been researched along with Gallstones in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, CM; Chiu, YH; Hou, CC; Lai, CC; Liu, WL | 1 |
| Baier, R; Puppel, H; Zehner, R; Zelder, O | 1 |
2 other study(ies) available for piperacillin and Gallstones
| Article | Year |
|---|---|
Biliary tract infection caused by Vibrio fluvialis in an immunocompromised patient.
Topics: Abdominal Pain; Aged, 80 and over; Anti-Bacterial Agents; Bile Ducts, Intrahepatic; Choledocholithiasis; Diabetes Mellitus; Diagnosis, Differential; Female; Gallstones; Humans; Immunocompromised Host; Kidney Failure, Chronic; Liver Cirrhosis; Penicillanic Acid; Piperacillin; Risk Factors; Taiwan; Tazobactam; Treatment Outcome; Vibrio; Vibrio Infections; Vomiting | 2011 |
[Piperacillin: pharmacokinetic studies on the biliary and renal excretion (author's transl)].
Topics: Bile; Cholecystectomy; Cholelithiasis; Dose-Response Relationship, Drug; Female; Gallstones; Humans; Injections, Intravenous; Kidney; Kinetics; Male; Metabolic Clearance Rate; Penicillins; Piperacillin | 1981 |